Hematology and Blood Components Practice Flashcards

Functions and Composition of Red Blood Cells (RBCs)

  • Oxygen Transport: Hemoglobin (Hb) serves to increase the maximum solubility of oxygen within the blood.

  • Carbonic Anhydrase Activity: RBCs contain carbonic anhydrase, which facilitates the reaction between carbon dioxide (CO2CO_2) and water (H2OH_2O) to form carbonic acid/bicarbonate ions (HCO3HCO_3^-). This is essential for gas transport.

  • Acid-Base Balance: Both Hemoglobin and bicarbonate ions function as powerful pH buffers for the blood, maintaining homeostasis.

  • Blood Composition:     * Hematocrit: This refers to the cellular component of the blood, which typically constitutes around 4045%40-45\%.     * Components include Red Blood Cells (RBCs) and leukocytes (White Blood Cells).

Morphology and Characteristics of Red Blood Cells

  • Shape: Described as a biconcave disc (resembling a donut without a hole).

  • Dimensions:     * Diameter: 7.8μm7.8\,\mu m     * Thickness: 2.5μm2.5\,\mu m

  • Structural Optimization: The biconcave shape is optimized for:     * Maximum elasticity and resistance to deformation when passing through tight spaces.     * Maximum surface area-to-volume ratio to facilitate efficient gas exchange.

  • Concentration in Blood:     * Men: Average of 5.2×106cells/mm35.2 \times 10^6\,\text{cells}/mm^3 (5.2 million).     * Women: Average of 4.7×106cells/mm34.7 \times 10^6\,\text{cells}/mm^3 (4.7 million).

  • Organelles: Mature RBCs lack a nucleus and other organelles.

  • Division: Mature RBCs are unable to divide.

Origin and Life Cycle of RBCs

  • Origin (Erythropoiesis): Erythrocytes are generated from Hematopoietic Stem Cells (HSPC).

  • Developmental Timeline:     * First few weeks of gestation: Produced in the yolk sac.     * Rest of gestation: Primarily produced in the liver.     * After birth: Produced in the bone marrow.

  • Average Lifespan: RBCs circulate for approximately 120days120\,\text{days} in a healthy person.

  • Fate of Senescent RBCs:     * Cells break down while passing through narrow capillaries, particularly in the spleen.     * They are captured and digested by macrophages.     * Heme Degradation: Iron is either released for reuse or stored. The porphyrin ring is secreted as bilirubin.

Regulation of Erythropoiesis

  • Expansion Inducers: Growth inducers such as Interleukin-3 (IL3IL-3) promote the expansion of stem cells.

  • Commitment Inducers: Differentiating inducers like Erythropoietin (EPO) promote commitment to a specific cell lineage.

  • Erythropoietin (EPO):     * Structure: A circulating 34kDa34\,kDa hormone.     * Source: Mainly produced in the kidneys.     * Trigger: Produced in response to low oxygen conditions (hypoxia) caused by high altitude, hemorrhage, or ischemia.     * Mechanism: Acts on EPO receptors located on Colony-Forming Unit-Erythrocyte (CFU-E) cells to drive differentiation.

Hemoglobin Synthesis and Assembly

  • Heme Biosynthesis Pathway:     * 2Succinyl-CoA+2Glycineδ-aminolevulinic acid (ALA)2\,\text{Succinyl-CoA} + 2\,\text{Glycine} \rightarrow \delta\text{-aminolevulinic acid (ALA)}.     * 2ALA1Porphobilinogen (PBG)2\,\text{ALA} \rightarrow 1\,\text{Porphobilinogen (PBG)}.     * 4PBGProtoporphyrin IX4\,\text{PBG} \rightarrow \text{Protoporphyrin IX}.     * Protoporphyrin IX+Fe3+Heme\text{Protoporphyrin IX} + Fe^{3+} \rightarrow \text{Heme}.

  • Regulation: A negative feedback loop exists where high concentrations of Heme inhibit the synthesis of ALA.

  • Hemoglobin Assembly:     * Hemoglobin is an iron-containing globular metalloprotein.     * Peptides called globins bind to heme to form a hemoglobin chain.     * Chains: There are $\alpha$-chains and $\beta$-chains.     * Quaternary Structure: A complete hemoglobin molecule is a tetramer composed of 2α-chains2\,\alpha\text{-chains} and 2β-chains2\,\beta\text{-chains}.     * Capacity: Each complete hemoglobin molecule can carry 4atoms4\,\text{atoms} of oxygen or carbon dioxide.

RBC Maturation and Nutritional Requirements

  • Requirements for DNA Replication: High levels of hematopoietic cell proliferation require a steady dietary supply of:     * Vitamin B12     * Folic Acid (Vitamin B9)

  • Deficiency Effects: A lack of these nutrients leads to maturation failure and the production of large, abnormal RBCs called macrocytes.

  • Iron Requirement: Heme production demands a steady supply of iron; low iron results in anemia.

Iron Metabolism

  • Body Reserves: Total iron in the human body averages 45g4-5\,g.

  • Distribution:     * 65%65\,\% is in Hemoglobin (RBCs).     * 1530%15-30\,\% is in Ferritin (stored in the liver).     * 4%4\,\% is in Myoglobin (found in muscles and the heart).     * 1%\approx 1\,\% is in Transferrin (circulating in plasma).

  • Absorption and Transport:     * Dietary iron binds to apotransferrin to form transferrin, which moves through the epithelium into the plasma.     * In tissues, Fe3+-boundFe^{3+}\text{-bound} transferrin is internalized into cells where it releases free iron.

  • Storage: Excess iron is stored as ferritin in the liver and, to a lesser extent, in the reticuloendothelial cells of the bone marrow.

  • Excretion: Iron is mostly excreted through feces, bound to bilirubin.

Pathophysiology: Types of Anemias

  • Blood Loss Anemia: Due to hemorrhage or donation. Plasma volume is restored in 13days1-3\,\text{days}, and RBC concentration returns to normal in 36weeks3-6\,\text{weeks}. Usually requires no treatment.

  • Aplastic Anemia: Caused by defective or absent RBC production in the bone marrow. Triggers include high-dose radiation, pesticides, toxic chemicals, or autoimmune diseases like Lupus. Primary treatment is blood transfusion.

  • Pernicious Anemia:     * Vitamin B12 must bind to Intrinsic Factor (secreted by gastric parietal cells) for absorption.     * Loss of the ability to secrete intrinsic factor leads to lower RBC levels.

  • Folic Acid Deficiency:     * Folic acid is found in fruit, vegetables, and organ meat, but is degraded by cooking.     * GI absorption disorders, such as sprue, can lead to RBC maturation failure.

  • Hemolytic Anemia (Sickle Cell Disease):     * Mutation in the Gene encoding the hemoglobin subunit $\beta$ (HBB).     * The $\beta^S$ allele results in a single amino acid substitution: Glutamate to Valine (Glu/Val).     * Under low oxygen, the subunits polymerize, causing the RBC to take a sickle shape, making it fragile and less effective.

Polycythemia

  • Definition: An increased number of RBCs (the opposite of anemia).

  • Physiological Polycythemia: Adaptation to chronic low oxygen conditions; common in individuals living at high altitudes.

  • Polycythemia Vera:     * Caused by a Janus kinase-2 (JAK2) mutation.     * Leads to neoplastic proliferation of hematopoietic progenitor cells.     * Complications include increased blood viscosity and thromboses.     * Treatment involves periodic removal of blood.

Leukocytes (White Blood Cells) and Platelets

  • Function: Protection against infections.

  • Counts:     * Approximately 7000WBCs/μL7000\,\text{WBCs}/\mu L (compared to 5 million RBCs).     * Platelets: Cell fragments numbering approximately 300,000/μL300,000/\mu L. They are replaced every 10days10\,\text{days}.

  • Origins:     * Myelocytes: Generated in the bone marrow (Neutrophils, Basophils, Eosinophils, Monocytes).     * Lymphocytes: Generated in the lymphatic system.

  • Lifespan:     * Granulocytes: 48hours4-8\,\text{hours} in circulation; 45days4-5\,\text{days} in tissue.     * Monocytes: 1020hours10-20\,\text{hours} in circulation; months in tissue.     * Lymphocytes: Weeks or months in circulation.

Morphology and Roles of Specific Leukocyte Types

  • Basophils / Mast Cells:     * Primary role in allergic reactions.     * Morphology: Bi- or poly-lobed nucleus often obscured by deep dark purple granules.     * Resident version in tissue is the Mast Cell (often at capillary beds).     * Mechanism: Possess IgE-antibodyIgE\text{-antibody} complexes that release histamine, bradykinin, serotonin, heparin, and lysosomal substances.

  • Eosinophils:     * Account for 2%2\,\% of all leukocytes.     * Morphology: Polynucleated acid-containing granules (intense red/pink on Wright staining).     * Specialize in multicellular parasites; release Larvicidal Polypeptide (Major Basic Protein) and oxidizing agents.

  • Neutrophils:     * Part of the polymorphonuclear (PMN) family.     * Very short-lived and highly motile.     * Engulf bacteria via pseudopodia (phagocytosis).     * Utilize Neutrophil Extracellular Traps (NETs) made of DNA, histones, and antimicrobial proteins.

  • Monocytes / Macrophages:     * Morphology: Clear cytoplasm with a large horseshoe-shaped nucleus.     * Differentiate into tissue macrophages, which are powerful phagocytes containing hydrolytic enzymes and oxidizing agents.

Macrophage Response and Chemotaxis

  • Resident Macrophages: First line of defense. Derived from the yolk sac and fetal liver; colonized tissues during development and stay for years as specialized sentinels.

  • Recruited Macrophages: Derived from circulating bone marrow monocytes during infection/injury. They are short-lived.

  • Chemotaxis: Leukocytes follow chemical gradients to reach infection sites.     * PAMPs: Pathogen Associated Molecular Patterns (e.g., bacterial/viral toxins).     * DAMPs: Damage Associated Molecular Patterns (from injured tissue).     * Detection occurs via specialized receptors like Toll-like receptors (TLRs) or cytokine/chemokine receptors.

  • Neutrophilia: An exponential increase in neutrophil numbers within hours of infection.

Multi-Line Defense and Phagocytosis

  • Phagocytosis Comparison:     * Neutrophils: Start immediately upon entering tissue; die after becoming exhausted.     * Macrophages: Slower response (due to differentiation) but longer-lasting; can engulf larger cells and act as Antigen Presenting Cells (APCs).

  • Progressive Immune Response:     * First Line: Resident macrophages.     * Second Line: Neutrophil invasion.     * Third Line: Monocyte wave (takes up to 8hours8\,\text{hours} to recruit).     * Fifth Line: Bone marrow increases production of progenitors resulting in WBC levels 2050times20-50\,\text{times} higher than normal.

  • Pus: Formed from dead neutrophils and macrophages that have engulfed pathogens.

Leukocyte Disorders

  • Leukopenia:     * Characterized by very low WBC counts, leaving the body unprotected.     * Symptoms: Ulcers, severe respiratory infections, potential death.     * Causes: Irradiation (X-rays, gamma rays), exposure to benzene or anthracene nuclei, chloramphenicol, or thiouracil.

  • Leukemia:     * Increased WBC count due to cancerous mutation.     * Lymphocytic: Cancerous production in lymph nodes.     * Myelogenous: Cancerous production of young myelogenous cells in the bone marrow.     * Results: Frequent infections, anemia, increased bone fractures, and nutrient starvation due to excessive cell division.